Safety and efficacy of intensive systolic blood pressure lowering after successful endovascular therapy: a post hoc analysis of the BP TARGET trial.
Anadani M, Maier B, Escalard S, Labreuche J, de Havenon A, Sabben C, Lapergue B, Mistry EA, Gory B, Spiotta AM, Richard S, Sibon I, Desilles JP, Blanc R, Piotin M, Mazighi M; of behalf the BP TARGET study group.
Anadani M, et al. Among authors: blanc r.
J Neurointerv Surg. 2023 Sep;15(e1):e142-e147. doi: 10.1136/jnis-2022-019130. Epub 2022 Oct 11.
J Neurointerv Surg. 2023.
PMID: 36220337